ema tirzepatide Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 26-29 January 2026 歐洲藥品管理局（EMA）最近也點頭，建議把tirzepatide的適應範圍擴大到10歲以上的兒童與青少年，用來治療控制不佳的第2型糖尿病。 根據SURPASS-PEDS第三期臨床試驗，小朋友使用之後，糖化血色素明顯下降，而且體重也跟著減輕不少。

As a board-certified, fellowship-trained surgeon with over a decade of experience and thousands of successful procedures, I offer a full spectrum of solutionsfrom advanced therapies like Tirzepatide (Mounjaro/Zepbound) , which targets both GLP-1 and GIP , to bariatric surgery

Slowing an infusion may help some rate-related symptomsbut does not diagnose them Chest symptoms, low blood pressure, breathing difficulty, severe pain, or neurologic symptoms require assessment rather than automatic continuation at a slower rate

When properly vetted, these providers can serve as trustworthy sources for safe and effective GLP-1 treatment at a more accessible price

With BCBS coverage + Lilly's savings card: as low as $25/month